Chronic antifibrotic and hemodynamic effects of a new liver specific no donor (V-PYRRO/NO) in bile duct ligated (BDL) rats.

被引：0
|
作者：
Moal, F [1 ]
Vuillemin, E [1 ]
Wang, JH [1 ]
Veal, N [1 ]
Oberti, F [1 ]
Cales, P [1 ]
机构：
[1] Univ Angers, Angers, France
来源：
HEPATOLOGY | 2000年 / 32卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
94
引用
收藏
页码：186A / 186A
页数：1
相关论文
共 48 条
  • [1] Chronic hemodynamic effects of a new liver specific NO donor (V-PYRRO/NO) in bile duct ligated (BDL) rats.
    Moal, F
    Vuillemin, E
    Wang, J
    Veal, N
    Oberti, F
    Cales, P
    GASTROENTEROLOGY, 2000, 118 (04) : A978 - A978
  • [2] Hemodynamic and antifibrotic effects of a selective liver nitric oxide donor V-PYRRO/NO in bile duct ligated rats
    Moal, Frederic
    Veal, Nary
    Vuillemin, Eric
    Barriere, Eric
    Wang, Jianhua
    Fizanne, Lionel
    Oberti, Frederic
    Douay, Olivier
    Gallois, Yves
    Bonnefont-Rousselot, Dominique
    Rousselet, Marie Christine
    Cales, Paul
    WORLD JOURNAL OF GASTROENTEROLOGY, 2006, 12 (41) : 6639 - 6645
  • [3] Hemodynamic and antifibrotic effects of a selective liver nitric oxide donor V-PYRRO/NO in bile duct ligated rats
    Frédéric Moal
    Nary Veal
    Eric Vuillemin
    Eric Barrière
    Lionel Fizanne
    Frédéric Oberti
    Olivier Douay
    Yves Gallois
    Dominique Bonnefont-Rousselot
    Marie Christine Roussele
    Paul Calès
    World Journal of Gastroenterology, 2006, (41) : 6639 - 6645
  • [4] Chronic hemodynamic and antifibrotic effects of a specific angiotensin II receptor antagonist (losartan) in bile duct ligated (BDL) rats and in portal vein ligated (PVL) rats
    Croquet, V
    Moal, F
    Oberti, F
    Wang, J
    Roux, J
    Veal, N
    Vuillemin, E
    Gallois, Y
    Douay, O
    Cales, P
    JOURNAL OF HEPATOLOGY, 2001, 34 : 88 - 88
  • [5] Anti-fibrotic effects of a new liver specific NO donor in bile duct ligated rats
    Moal, F
    Vuillemin, E
    Wang, J
    Veal, N
    Oberti, E
    Gallois, Y
    Barriere, E
    Rousselot, D
    Cales, P
    JOURNAL OF HEPATOLOGY, 2001, 34 : 5 - 6
  • [6] Ursodeoxycholate inhibits the increased cholangiocyte secretion and proliferation in bile duct ligated (BDL) rats.
    Baiocchi, L
    Alpini, G
    Glaser, S
    Francis, H
    Phinizy, J
    Rodgers, R
    Eisel, W
    LeSage, G
    HEPATOLOGY, 1998, 28 (04) : 535A - 535A
  • [7] EFFECTS OF LIVER-SPECIFIC NO-DONOR, V-PYRRO/NO ON LIVER STEATOSIS IN MICE FED HIGH FAT DIET
    Maslak, E.
    Jasztal, A.
    Kochan, K.
    Sitek, B.
    Zabielski, P.
    Chabowski, A.
    Kus, K.
    Walczak, M.
    Proniewski, B.
    Baranska, M.
    Keefer, L.
    Chlopicki, S.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S161 - S161
  • [8] Chronic hemodynamic and antifibrotic effects of vapreotide in cirrhotic rats.
    Moal, F
    Oberti, F
    Pilette, C
    Veal, N
    Kaassis, M
    Fort, J
    Calès, P
    HEPATOLOGY, 1998, 28 (04) : 559A - 559A
  • [9] Hemodynamic effects of Salvia miltiorrhiza on bile duct ligated rats
    Lee, TY
    Huang, YT
    Lin, HC
    JOURNAL OF HEPATOLOGY, 2000, 32 : 211 - 211
  • [10] Antifibrotic activity of the liver growth factor in bile duct ligated rats.: Implications for hepatic stellate cells as main target
    Diaz-Gil, Juan J.
    Garcia-Monzon, Carmelo
    Rua, Carmen
    Martin-Sanz, Paloma
    Miquilena-Colina, Maria E.
    Machin, Celia
    Fernandez-Martinez, Amalia
    Garcia-Canero, Rafael
    HEPATOLOGY, 2006, 44 (04) : 580A - 581A
12345